Neural Analytics Inc., a Los Angeles, CA-based medical device company focused on developing devices and services to measure, diagnose and track brain health, secured $10m in Series A financing.
Backers included new investors JSR Limited and Taiyu Capital.
The company, which has raised $13m to date, intends to use the funds to support clinical trials in 2016 and ongoing development of new products and continuing research studies on Traumatic Brain Injury (TBI) including athletes who play sports with a high risk of concussion.
Led by Leo Petrossian, PhD, co-founder and Chief Executive Officer, Neural Analytics is creating products and services to measure, diagnose and track brain health with a current focus on Traumatic Brain Injury (TBI). The company combines edge data science with medical robotics to allow first responders and clinicians to accurately assess mild to severe TBI, including concussions.